Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2019
Aug. 06, 2019
Document and Entity Information    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Entity Registrant Name EYEGATE PHARMACEUTICALS INC  
Entity Current Reporting Status Yes  
Entity Central Index Key 0001372514  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Trading Symbol EYEG  
Entity Common Stock, Shares Outstanding   45,675,737
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period true  
Entity Small Business true